Gastrointestinal Stromal Tumors
Showing 26 - 50 of >10,000
Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)
Active, not recruiting
- Gastrointestinal Stromal Tumor (GIST)
- MEK162
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 28, 2022
Metastatic or Unresectable Gastrointestinal Stromal Tumors
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 16, 2022
Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2023
A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Completed
- Neuroendocrine Tumors
- +2 more
- FNB group
- FNA group
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, HUST
Nov 26, 2022
Ripretinib Combined With Surgery in Advanced GIST That Have
Recruiting
- Gastrointestinal Stromal Tumor(GIST)
- Resection surgery of gastrointestinal stromal tumor
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Apr 25, 2022
Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic
Recruiting
- Unresectable Gastrointestinal Stromal Tumor (GIST)
- +2 more
- Atezolizumab 1200 mg
- Imatinib 400 MG
-
Lyon, Rhône, France
- +4 more
Apr 28, 2022
Gastrointestinal Stromal Tumors Trial in Beijing, Guangzhou (CS3007 (BLU-285))
Active, not recruiting
- Gastrointestinal Stromal Tumors
- CS3007 (BLU-285)
-
Beijing, Beijing, China
- +1 more
Apr 25, 2022
Unifying Advanced Treatment With Advanced Imaging
Completed
- Gastrointestinal Stromal Tumor (GIST)
- Dual Energy CT
-
Mannheim, GermanyUniversity Center Mannheim
Apr 6, 2022
Second-line Pharmacotherapy Patterns and Outcomes of Advanced
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital,Sun yat-sen university
Jun 30, 2022
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)
Recruiting
- Advanced Gastrointestinal Stromal Tumors
- Metastatic Cancer
- CGT9486 plus sunitinib
- +2 more
-
Duarte, California
- +11 more
Aug 10, 2022
Regorafenib Post-marketing Surveillance in Japan
Completed
- Gastrointestinal Stromal Tumors
- Regorafenib (Stivarga, BAY73-4506)
-
Multiple Locations, Japan(unnamed)
Mar 21, 2022
Ripretinib in Chinese Advanced GIST: a Real World Study
Active, not recruiting
- Gastrointestinal Stromal Tumors
- Ripretinib Oral Tablet
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 15, 2023
GIST Trial in Xi'an (Imatinib)
Recruiting
- GIST
-
Xi'an, Shaanxi, ChinaXijing Hospital of Air Force Military Medical University
Jun 8, 2023
Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)
Withdrawn
- Gastrointestinal Stromal Tumors
- (no location specified)
Dec 15, 2021
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Recruiting
- Gastro-intestinal Stromal Tumor
- Vena puncture for blood collection
- Tumor biopsy
-
Amsterdam, Netherlands
- +4 more
May 17, 2022
Gastrointestinal Stromal Tumors Trial in Villejuif (Avapritinib)
Active, not recruiting
- Gastrointestinal Stromal Tumors
-
Villejuif, Val-de-Marne, FranceGustave Roussy Cancer Campus Grand Paris Institut de Cancerologi
May 16, 2022
Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)
Not yet recruiting
- Liver Diseases
- +27 more
- Liver Transplantation
-
Murcia, SpainFelipe Alconchel
Feb 24, 2022
Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Recruiting
- Gastrointestinal Stromal Tumors
- Minimal Residual Disease
- liquid biopsy
-
Beijing, Beijing, ChinaPeking University People'S Hospital
Sep 18, 2022
Gastrointestinal Stromal Tumor Trial in Los Angeles (Ipilimumab, Laboratory Biomarker Analysis, Nivolumab)
Completed
- Gastrointestinal Stromal Tumor
- Ipilimumab
- +2 more
-
Los Angeles, CaliforniaRachel Andes
Aug 15, 2022
Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)
Completed
- Gastrointestinal Stromal Tumors (GIST)
- Other Relapsed or Refractory Solid Tumors
-
Scottsdale, Arizona
- +18 more
May 20, 2022
Gastrointestinal Stromal Tumor, Malignant Trial in Changsha (Entacapone, Imatinib Mesylate)
Active, not recruiting
- Gastrointestinal Stromal Tumor, Malignant
- Entacapone
- Imatinib Mesylate
-
Changsha, Hunan, ChinaBin Li, MD
Nov 24, 2021
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
Completed
- GIST
- Gastrointestinal Stromal Tumors
-
Beijing, China
- +2 more
Jun 1, 2022
Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)
Completed
- GIST
- Treatment of Low Risk GISTs according clinical practice (includes drugs, surgery or any other received treatments)
-
Bologna, BO, Italy
- +12 more
Sep 16, 2022
Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 15, 2022